Politico May 10, 2023
By Alice Miranda Ollstein and Katherine Ellen Foley

The agency is slated to make a decision on approval of the daily hormonal pill by this summer.

The Biden administration has long vowed to “follow the science” on drug approvals. But it has also pledged to aggressively defend reproductive rights.

Those two promises could clash this week as two FDA panels of expert advisers vote whether to recommend the agency approve the country’s first non-prescription birth control pill.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article